Danaher Corporation $DHR Shares Sold by Nordea Investment Management AB

Nordea Investment Management AB cut its holdings in shares of Danaher Corporation (NYSE:DHR) by 1.0% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 1,826,112 shares of the conglomerate’s stock after selling 18,574 shares during the quarter. Nordea Investment Management AB owned 0.26% of Danaher worth $420,681,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of DHR. JPL Wealth Management LLC purchased a new position in shares of Danaher during the 3rd quarter valued at about $25,000. WFA of San Diego LLC acquired a new position in shares of Danaher in the 2nd quarter valued at about $26,000. Howard Hughes Medical Institute purchased a new stake in shares of Danaher in the second quarter worth about $27,000. ANTIPODES PARTNERS Ltd acquired a new stake in Danaher during the third quarter worth about $27,000. Finally, TruNorth Capital Management LLC acquired a new stake in Danaher during the third quarter worth about $28,000. 79.05% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

DHR has been the subject of a number of analyst reports. Weiss Ratings reissued a “hold (c)” rating on shares of Danaher in a report on Monday, December 29th. Morgan Stanley started coverage on shares of Danaher in a research note on Monday, December 1st. They set an “overweight” rating and a $270.00 price objective on the stock. Argus set a $265.00 target price on shares of Danaher in a report on Wednesday, January 14th. The Goldman Sachs Group lowered their price target on shares of Danaher from $270.00 to $265.00 and set a “buy” rating on the stock in a report on Thursday, January 29th. Finally, JPMorgan Chase & Co. raised their price target on shares of Danaher from $270.00 to $275.00 and gave the company an “overweight” rating in a research report on Thursday, January 29th. Nineteen equities research analysts have rated the stock with a Buy rating and three have given a Hold rating to the company’s stock. Based on data from MarketBeat.com, Danaher currently has a consensus rating of “Moderate Buy” and an average price target of $253.55.

Danaher Stock Down 0.3%

Shares of DHR opened at $189.46 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.51 and a debt-to-equity ratio of 0.35. Danaher Corporation has a 12 month low of $171.00 and a 12 month high of $242.80. The stock’s 50 day moving average is $214.33 and its two-hundred day moving average is $214.93. The firm has a market cap of $133.97 billion, a P/E ratio of 37.59, a PEG ratio of 2.57 and a beta of 0.93.

Danaher (NYSE:DHR) last posted its quarterly earnings data on Tuesday, January 27th. The conglomerate reported $2.23 EPS for the quarter, beating analysts’ consensus estimates of $2.14 by $0.09. The business had revenue of $6.84 billion during the quarter, compared to analysts’ expectations of $6.79 billion. Danaher had a return on equity of 10.81% and a net margin of 14.71%.The business’s revenue was up 4.6% compared to the same quarter last year. During the same period in the previous year, the business earned $2.14 earnings per share. Analysts predict that Danaher Corporation will post 7.63 earnings per share for the current fiscal year.

Danaher Increases Dividend

The business also recently declared a quarterly dividend, which will be paid on Friday, April 24th. Investors of record on Friday, March 27th will be issued a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.8%. The ex-dividend date of this dividend is Friday, March 27th. This is a boost from Danaher’s previous quarterly dividend of $0.32. Danaher’s payout ratio is presently 25.40%.

Insider Buying and Selling

In other Danaher news, EVP Gregory M. Milosevich sold 1,320 shares of the company’s stock in a transaction on Thursday, February 19th. The shares were sold at an average price of $208.01, for a total transaction of $274,573.20. Following the completion of the transaction, the executive vice president directly owned 5,099 shares in the company, valued at approximately $1,060,642.99. This represents a 20.56% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. Insiders own 11.10% of the company’s stock.

Danaher Profile

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.